Cargando…
Atrial Heterogeneity Generates Re-entrant Substrate during Atrial Fibrillation and Anti-arrhythmic Drug Action: Mechanistic Insights from Canine Atrial Models
Anti-arrhythmic drug therapy is a frontline treatment for atrial fibrillation (AF), but its success rates are highly variable. This is due to incomplete understanding of the mechanisms of action of specific drugs on the atrial substrate at different stages of AF progression. We aimed to elucidate th...
Autores principales: | Varela, Marta, Colman, Michael A., Hancox, Jules C., Aslanidi, Oleg V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161306/ https://www.ncbi.nlm.nih.gov/pubmed/27984585 http://dx.doi.org/10.1371/journal.pcbi.1005245 |
Ejemplares similares
-
Image-Based Computational Evaluation of the Effects of Atrial Wall Thickness and Fibrosis on Re-entrant Drivers for Atrial Fibrillation
por: Roy, Aditi, et al.
Publicado: (2018) -
Computed tomography model-based treatment of atrial fibrillation and atrial macro-re-entrant tachycardia
por: Piorkowski, Christopher, et al.
Publicado: (2008) -
Identifying locations of re-entrant drivers from patient-specific distribution of fibrosis in the left atrium
por: Roy, Aditi, et al.
Publicado: (2020) -
Pro-arrhythmogenic effects of atrial fibrillation-induced electrical remodelling: insights from the three-dimensional virtual human atria
por: Colman, Michael A, et al.
Publicado: (2013) -
Intra-atrial Re-entrant Tachycardia
with Wenckebach Periodicity
por: Sarubbi, Berardo, et al.
Publicado: (2003)